GlassScriptPhysician profile
Nathan Fletcher
NPI 1568098911
$5,349.30
in general payments reported to CMS, 2019-2025
22 companies · $2,425 in 2025
The $2,425 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $442 · 2024: $2,483 · 2025: $2,425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,168 · Travel and Lodging: $1,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,167.84 |
| Travel and Lodging | $1,181.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $1,567.74 | 2024 | |
| Trimed, INC. | $824.12 | 2025 | |
| Paratek Pharmaceuticals, INC. | $391.07 | 2023-2025 | Nuzyra |
| Kerecis Limited | $308.68 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Ibsa Pharma INC. | $300.76 | 2023-2025 | Licart, Tirosint, Flector |
| Pacira Pharmaceuticals Incorporated | $250.00 | 2025 | Exparel |
| Alexion Pharmaceuticals, INC. | $247.17 | 2024-2025 | Strensiq |
| Stryker Corporation | $237.07 | 2024-2025 | Prostep Mica, Actishield, Citrefix |
| Angiodynamics, INC. | $209.14 | 2025 | Auryon Laser System 100-120 Vac |
| Solventum Corporation | $193.22 | 2024-2025 | V.A.C.Ulta, Activ.A.C., V.A.C. Veraflo |
| Nevro Corp. | $168.83 | 2023 | Senza |
| Integra Lifesciences Corporation | $166.05 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bone Support INC. | $96.92 | 2025 | Cerament G, Ceramentbone Void Filler |
| Convatec INC. | $82.89 | 2024 | |
| Orthofix Medical, INC. | $77.90 | 2025 | Physio-Stim |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $56.92 | 2024-2025 | Collagenase Santyl |
| Treace Medical Concepts, INC. | $53.57 | 2025 | |
| Acumed LLC | $44.43 | 2025 | Osteomed, Acumed, Innate Implant |
| Averitas Pharma INC. | $24.49 | 2025 | Qutenza |
| Metric Medical Devices, INC. | $16.66 | 2023 | Super Scaffold, Super Staple |
| Eclipse Technology Solutions INC. | $16.08 | 2025 | |
| Paladin Technology Solutions | $15.59 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Fletcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.